Please use this identifier to cite or link to this item:
https://doi.org/10.1182/blood-2009-12-256149
Title: | Mutant nucleophosmin deregulates cell death and myeloid differentiation through excessive caspase-6 and -8 inhibition | Authors: | Leong, S.M. Tan, B.X. Ahmad, B.B. Yan, T. Chee, L.Y. Ang, S.T. Tay, K.G. Koh, L.P. Yeoh, A.E.J. Koay, E.S.-C. Mok, Y.-K. Lim, T.M. |
Issue Date: | 28-Oct-2010 | Citation: | Leong, S.M., Tan, B.X., Ahmad, B.B., Yan, T., Chee, L.Y., Ang, S.T., Tay, K.G., Koh, L.P., Yeoh, A.E.J., Koay, E.S.-C., Mok, Y.-K., Lim, T.M. (2010-10-28). Mutant nucleophosmin deregulates cell death and myeloid differentiation through excessive caspase-6 and -8 inhibition. Blood 116 (17) : 3286-3296. ScholarBank@NUS Repository. https://doi.org/10.1182/blood-2009-12-256149 | Abstract: | In up to one-third of patients with acute myeloid leukemia, a C-terminal frame-shift mutation results in abnormal and abundant cytoplasmic accumulation of the usually nucleoli-bound protein nucleophosmin (NPM), and this is thought to function in cancer pathogenesis. Here, we demonstrate a gain-of-function role for cytoplasmic NPM in the inhibition of caspase signaling. The NPM mutant specifically inhibits the activities of the cell-death proteases, caspase-6 and -8, through direct interaction with their cleaved, active forms, but not the immature procaspases. The cytoplasmic NPM mutant not only affords protection from death ligand-induced cell death but also suppresses caspase-6/-8-mediated myeloid differentiation. Our data hence provide a potential explanation for the myeloid-specific involvement of cytoplasmic NPM in the leukemogenesis of a large subset of acute myeloid leukemia. © 2010 by The American Society of Hematology. | Source Title: | Blood | URI: | http://scholarbank.nus.edu.sg/handle/10635/115823 | ISSN: | 00064971 | DOI: | 10.1182/blood-2009-12-256149 |
Appears in Collections: | Staff Publications |
Show full item record
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.